Successful first patient treated in Amsterdam, major insurance companies are starting to adopt and approve the OncoSil device as appropriate treatment for pancreatic cancer, and the list goes on. The proof is in the pudding. Big move from OncoSil.
OncoSil Insurance Adoption
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $14.88M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $41.37K | 9.733M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 15920808 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29092158 | 14 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.001 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 560000 | ||
| Last updated 14.39pm 03/05/2024 ? | |||||
| OSL (ASX) Chart |